supp.fit

Lupin

12 benefits mapped to clinical evidence across supplements.

Dose per serving from research

8 study groups in 7 studies say how much Lupin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 g to 25 g, 75% of 8 study groups.

Daily doseStudy groups
10 g to 25 g
6
25 g to 50 g
2

See every study group

Benefit Evidence

Metabolism
Moderate

Lipids: LDL/TC −4%

Glycemia: GI/glucose ↓

833 people

LDL/total cholesterol ↓

Protein digestibility ↓

461 people
Heart health
Moderate

Lower LDL/total cholesterol

Better LDL:HDL ratio

421 people
Satiety
Moderate

Satiety + fullness

-488kJ intake

Ghrelin down

346 people

Bulk ↑, transit ↓

+33%, -21%

Frequent, higher output

214 people

Muscle loss −3.5%

Strength loss −9.7%

342 people

Bulk +33%

Transit -21%

Butyrate +60%

176 people

Bulk +33%

Transit -21%

176 people

Satiety −488 kJ

Weight loss −7.4 kg

352 people

Cholesterol/LDL ↓ ~4%

Protein/Zn uptake ↑

247 people

HbA1c −2.9%, comfort ↑

Weight −7.4kg, comfort ↑

319 people

Lower hunger, −488 kJ

Blunted glucose spikes, ~−73%

33 people

Research sources

Metabolism (7)
  1. Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control

    PubMed ID: 39634180

    Digital‑twin personalized nutrition produced large HbA1c reductions and weight loss — directly relevant to metabolic improvement.

  2. Consuming a mixed diet enriched with lupin protein beneficially affects plasma lipids in hypercholesterolemic subjects: a randomized controlled trial

    PubMed ID: 24746974

    Crossover RCT showed lupin protein lowered LDL and other cardiometabolic markers in hypercholesterolemic subjects.

  3. Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

    PubMed ID: 22032303

    Lupin protein reduced total and LDL cholesterol in an RCT—evidence for beneficial metabolic effects.

  4. The formation of short-chain fatty acids is positively associated with the blood lipid-lowering effect of lupin kernel fiber in moderately hypercholesterolemic adults

    PubMed ID: 24572041

    Lupin kernel fiber lowered total, LDL cholesterol and triglycerides in a controlled trial—supports metabolic benefit.

  5. Lupin protein compared to casein lowers the LDL cholesterol:HDL cholesterol-ratio of hypercholesterolemic adults

    PubMed ID: 19680704

    Replacing protein with lupin protein modestly lowered LDL and improved LDL:HDL ratio in hypercholesterolemic adults (metabolic/cardio risk marker).

  6. Effects of lupin-enriched foods on body composition and cardiovascular disease risk factors: a 12-month randomized controlled weight loss trial

    PubMed ID: 20938438

    12‑month lupin‑enriched foods improved fasting insulin and HOMA (insulin sensitivity) despite no weight change.

  7. Lupin protein positively affects plasma LDL cholesterol and LDL:HDL cholesterol ratio in hypercholesterolemic adults after four weeks of supplementation: a randomized, controlled crossover study

    PubMed ID: 23902673

    Randomized human trial: 25 g/day lupin protein lowered LDL and systolic BP — favorable metabolic/cardiovascular markers.

Protein source (6)
  1. Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial

    PubMed ID: 24060277

    Lupin kernel fibre trial shows significant fiber and colonic metabolite benefits—contributes to plant‑based nutritional value.

  2. Consuming a mixed diet enriched with lupin protein beneficially affects plasma lipids in hypercholesterolemic subjects: a randomized controlled trial

    PubMed ID: 24746974

    25 g/day lupin protein in a randomized crossover trial vs milk protein—supports lupin as a high‑quality plant protein.

  3. Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

    PubMed ID: 22032303

    Direct RCT using 25 g/day lupin protein (bars) demonstrating meaningful dietary replacement—strong evidence lupin is an effective plant protein source.

  4. Lupin protein positively affects plasma LDL cholesterol and LDL:HDL cholesterol ratio in hypercholesterolemic adults after four weeks of supplementation: a randomized, controlled crossover study

    PubMed ID: 23902673

    Human RCT with lupin protein isolate showing cardiometabolic benefits at dietary dosing — supports plant-based nutrition claims.

  5. Lupin protein compared to casein lowers the LDL cholesterol:HDL cholesterol-ratio of hypercholesterolemic adults

    PubMed ID: 19680704

    Lupin protein substituted for casein in RCT and produced metabolic benefits — supports use as plant protein.

  6. The formation of short-chain fatty acids is positively associated with the blood lipid-lowering effect of lupin kernel fiber in moderately hypercholesterolemic adults

    PubMed ID: 24572041

    Four‑week lupin kernel fiber RCT demonstrates plant‑derived fiber benefits on lipids and SCFA production.

Heart health (6)
  1. Consuming a mixed diet enriched with lupin protein beneficially affects plasma lipids in hypercholesterolemic subjects: a randomized controlled trial

    PubMed ID: 24746974

    Crossover RCT: lupin protein lowered LDL, homocysteine and other cardio‑metabolic markers in hypercholesterolemic subjects.

  2. Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

    PubMed ID: 22032303

    Randomized dietary trial showed lupin protein (25 g/day) significantly lowered total cholesterol and LDL—strong evidence for cardiovascular risk factor improvement.

  3. Lupin protein positively affects plasma LDL cholesterol and LDL:HDL cholesterol ratio in hypercholesterolemic adults after four weeks of supplementation: a randomized, controlled crossover study

    PubMed ID: 23902673

    Randomized human trial: lupin protein isolate (25 g/day) lowered LDL (notably in higher-baseline subgroup) and reduced systolic BP by ~8 mmHg — strong direct cardiometabolic benefit.

  4. Lupin kernel fibre-enriched foods beneficially modify serum lipids in men

    PubMed ID: 15508014

    One‑month lupin kernel fibre reduced total and LDL cholesterol in healthy men — cardio‑metabolic benefit.

  5. Lupin protein compared to casein lowers the LDL cholesterol:HDL cholesterol-ratio of hypercholesterolemic adults

    PubMed ID: 19680704

    Six‑week RCT: replacing protein with lupin protein modestly lowered LDL and improved LDL:HDL ratio in hypercholesterolemic adults.

  6. The formation of short-chain fatty acids is positively associated with the blood lipid-lowering effect of lupin kernel fiber in moderately hypercholesterolemic adults

    PubMed ID: 24572041

    Lupin kernel fiber reduced total, LDL cholesterol and triglycerides in a randomized, controlled crossover trial—robust lipid benefits.

Satiety (4)
  1. Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial

    PubMed ID: 24060277

    Lupin fibre increases bulk and SCFA which are associated with satiety; fullness was not directly measured but is plausible.

  2. Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

    PubMed ID: 22032303

    Lupin protein (25 g/day) is likely to promote satiety relative to lower‑protein alternatives (indirect evidence from protein intervention).

  3. Lupin-enriched bread increases satiety and reduces energy intake acutely

    PubMed ID: 17093146

    Lupin‑enriched bread markedly increased subjective satiety and reduced subsequent intake in crossover trials.

  4. The formation of short-chain fatty acids is positively associated with the blood lipid-lowering effect of lupin kernel fiber in moderately hypercholesterolemic adults

    PubMed ID: 24572041

    Lupin fiber intervention increases SCFA and fiber intake—mechanistically consistent with prolonged fullness (indirect).

Bowel regularity (4)
  1. Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial

    PubMed ID: 24060277

    Lupin kernel fibre trials increased stool bulk, sped transit and raised butyrate—direct high‑quality evidence lupin is an effective natural fiber source.

  2. The formation of short-chain fatty acids is positively associated with the blood lipid-lowering effect of lupin kernel fiber in moderately hypercholesterolemic adults

    PubMed ID: 24572041

    Four‑week RCT (25 g/d lupin kernel fiber) produced measurable physiological benefits (lipids, SCFA)—strong fiber evidence.

  3. Lupin kernel fibre foods improve bowel function and beneficially modify some putative faecal risk factors for colon cancer in men

    PubMed ID: 16469156

    Direct human evidence: lupin kernel fibre improved bowel habits and faecal biomarkers — strong evidence as a fiber source.

  4. Lupin kernel fibre-enriched foods beneficially modify serum lipids in men

    PubMed ID: 15508014

    One‑month lupin kernel fibre reduced cholesterol and improved lipid ratios — typical benefits of viscous/fermentable fibre.

Muscle maintenance (3)
  1. Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

    PubMed ID: 22032303

    Trial used substantial lupin protein (25 g/day) demonstrating that lupin is a significant plant protein source supportive of muscle maintenance.

  2. Consuming a mixed diet enriched with lupin protein beneficially affects plasma lipids in hypercholesterolemic subjects: a randomized controlled trial

    PubMed ID: 24746974

    Lupin protein intervention vs milk protein supports lupin as a protein source; relevant to preserving lean mass (indirect evidence).

  3. Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease

    PubMed ID: 39535661

    Switching enzyme therapy in Pompe disease improved walk distance and breathing measures — directly relevant to muscle function/maintenance in a muscle disease context.

Digestive support (3)
  1. The formation of short-chain fatty acids is positively associated with the blood lipid-lowering effect of lupin kernel fiber in moderately hypercholesterolemic adults

    PubMed ID: 24572041

    Four‑week lupin kernel fiber lowered lipids and increased SCFA production; supports beneficial gut physiological effects.

  2. Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial

    PubMed ID: 24060277

    Two‑week lupin kernel fibre RCT increased faecal weight, shortened transit time and raised butyrate—strong direct evidence for gut comfort/colon health.

  3. Lupin kernel fibre foods improve bowel function and beneficially modify some putative faecal risk factors for colon cancer in men

    PubMed ID: 16469156

    Randomized feeding (38 men): lupin kernel fibre improved defecation frequency, transit time and faecal butyrate — clear gut comfort effects.

Stomach comfort (3)
  1. Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial

    PubMed ID: 24060277

    Lupin kernel fibre increased stool bulk and transit without reported adverse GI effects in the short trial—suggests tolerability, but evidence is limited.

  2. The formation of short-chain fatty acids is positively associated with the blood lipid-lowering effect of lupin kernel fiber in moderately hypercholesterolemic adults

    PubMed ID: 24572041

    Four‑week controlled trial reported physiological benefits with no notable tolerability signals—indirect support for being gentle in studied doses.

  3. Liking of health-functional foods containing lupin kernel fibre following repeated consumption in a dietary intervention setting

    PubMed ID: 20542068

    Repeated daily consumption of lupin‑fibre foods was well tolerated with no drop in overall liking — practical tolerability signal.

Weight management (2)
  1. Lupin-enriched bread increases satiety and reduces energy intake acutely

    PubMed ID: 17093146

    Acute reductions in subsequent energy intake after lupin‑enriched bread suggest potential to support weight control.

  2. Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control

    PubMed ID: 39634180

    Personalized nutrition intervention achieved marked weight loss — directly relevant to weight‑support benefits.

Nutrition source (2)
  1. Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

    PubMed ID: 22032303

    Lupin protein supplementation (25 g/day) provides substantial plant protein and improved serum lipids—supports the idea of a nutrient/protein boost.

  2. Consuming a mixed diet enriched with lupin protein beneficially affects plasma lipids in hypercholesterolemic subjects: a randomized controlled trial

    PubMed ID: 24746974

    Randomized crossover with lupin protein (25 g/day) demonstrates nutritional replacement effects vs milk protein.

Daily comfort (1)
  1. Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control

    PubMed ID: 39634180

    Sustained improvements in HbA1c, weight and liver fat indicate broad daily‑wellness benefits from a comprehensive nutrition program.

Appetite suppression (1)
  1. Lupin-enriched bread increases satiety and reduces energy intake acutely

    PubMed ID: 17093146

    Acute crossover trials: lupin‑enriched bread increased satiety, lowered subsequent intake and suppressed ghrelin vs white bread.

Similar by evidence

Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.